Immediate Impact
1 from Science/Nature 55 standout
Citing Papers
Advances in diagnosis and treatment of bladder cancer
2024 Standout
Targeting the Warburg Effect in Cancer: Where Do We Stand?
2024 Standout
Works of Francesca Vignani being referenced
Randomized phase II study of niraparib plus best supportive care (BSC) versus BSC alone as maintenance treatment in patients with advanced urothelial carcinoma (UC) whose disease did not progress after first-line platinum-based chemotherapy (PBCT): The Meet-URO12 trial.
2022
Prognostic impact of pretreatment neutrophil-to-lymphocyte ratio in castration-resistant prostate cancer patients treated with first-line docetaxel
2017
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Francesca Vignani | 492 | 251 | 180 | 182 | 45 | 719 | |
| Michael Kolinsky | 537 | 339 | 190 | 160 | 53 | 772 | |
| Salvatore Luca Burgio | 593 | 305 | 243 | 164 | 39 | 841 | |
| Amelia Altavilla | 452 | 225 | 160 | 141 | 42 | 694 | |
| Laura‐Maria Krabbe | 426 | 151 | 175 | 122 | 46 | 637 | |
| Alan D. Smith | 351 | 229 | 164 | 227 | 35 | 618 | |
| Yasuhide Kitagawa | 281 | 207 | 112 | 280 | 45 | 762 | |
| Yusuke Imamura | 376 | 147 | 161 | 305 | 73 | 715 | |
| C Mossetti | 345 | 373 | 75 | 128 | 31 | 731 | |
| Marcel Trautmann | 410 | 175 | 92 | 209 | 46 | 747 | |
| Peter Hammerer | 459 | 166 | 103 | 184 | 52 | 833 |
All Works
Login with ORCID to disown or claim papers
Loading papers...